Tafasitamab HY-P9981 from MedChemExpress | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
MedChemExpress for
Tafasitamab

Description

Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19

Product Specs
ItemTafasitamab
CompanyMedChemExpress
Price $290.00Supplier Page View Company Product Page
Catalog NumberHY-P9981
Quantity1 mg
TypeChemical
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity98.53%
Research AreaInflammation/Immunology; Cancer
Molecule NameTafasitamab

Add to Compare List

MedChemExpress

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapyCancer immunology, immunotherapy : CIINovember 1, 2022Her JH, Pretscher D, Patra-Kneuer M, Schanzer J, Cho SY, Hwang YK, Hoeres T, Boxhammer R, Heitmueller C, Wilhelm M, et al.

(2) Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemiaCancer researchOctober 1, 2008Horton HM, Bernett MJ, Pong E, Peipp M, Karki S, Chu SY, Richards JO, Vostiar I, Joyce PF, Repp R, et al.

Be the First to Write a Review!